▶ 調査レポート

磁気共鳴画像法(MRI)用造影剤の世界市場(~2026年)

• 英文タイトル:Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。磁気共鳴画像法(MRI)用造影剤の世界市場(~2026年) / Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Insights and Forecast to 2026 / MRC2-11QY00615資料のイメージです。• レポートコード:MRC2-11QY00615
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は磁気共鳴画像法(MRI)用造影剤のグローバル市場について調査・分析したレポートです。種類別(バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤)市場規模、用途別(放射線科、インターベンショナルラジオロジー、インターベンショナルカーディオロジー)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別磁気共鳴画像法(MRI)用造影剤の競争状況、市場シェア
・世界の磁気共鳴画像法(MRI)用造影剤市場:種類別市場規模 2015年-2020年(バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤)
・世界の磁気共鳴画像法(MRI)用造影剤市場:種類別市場規模予測 2021年-2026年(バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤)
・世界の磁気共鳴画像法(MRI)用造影剤市場:用途別市場規模 2015年-2020年(放射線科、インターベンショナルラジオロジー、インターベンショナルカーディオロジー)
・世界の磁気共鳴画像法(MRI)用造影剤市場:用途別市場規模予測 2021年-2026年(放射線科、インターベンショナルラジオロジー、インターベンショナルカーディオロジー)
・北米の磁気共鳴画像法(MRI)用造影剤市場分析:米国、カナダ
・ヨーロッパの磁気共鳴画像法(MRI)用造影剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの磁気共鳴画像法(MRI)用造影剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の磁気共鳴画像法(MRI)用造影剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの磁気共鳴画像法(MRI)用造影剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GE Healthcare (US)、Bracco Imaging (Italy)、Bayer HealthCare (Germany)、Guerbet (France)、Lantheus (US)、Daiichi Sankyo (Japan)、Unijules Life Sciences (India)、J.B. Chemicals and Pharmaceuticals (India)、Spago Nanomedicine (Sweden)、Taejoon Pharm (South Korea)、Jodas (India)、Magnus Health (India)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market
The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Scope and Market Size
Contrast Agents for Magnetic Resonance Imaging (MRI) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Contrast Agents for Magnetic Resonance Imaging (MRI) market is segmented into
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media

Segment by Application, the Contrast Agents for Magnetic Resonance Imaging (MRI) market is segmented into
Radiology
Interventional Radiology
Interventional Cardiology

Regional and Country-level Analysis
The Contrast Agents for Magnetic Resonance Imaging (MRI) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Contrast Agents for Magnetic Resonance Imaging (MRI) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share Analysis
Contrast Agents for Magnetic Resonance Imaging (MRI) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Contrast Agents for Magnetic Resonance Imaging (MRI) business, the date to enter into the Contrast Agents for Magnetic Resonance Imaging (MRI) market, Contrast Agents for Magnetic Resonance Imaging (MRI) product introduction, recent developments, etc.

The major vendors covered:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

レポート目次

1 Study Coverage
1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
1.2 Market Segments
1.3 Key Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type
1.4.2 Barium-based Contrast Media
1.4.3 Iodinated Contrast Media
1.4.4 Gadolinium-based Contrast Media
1.4.5 Microbubble Contrast Media
1.5 Market by Application
1.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application
1.5.2 Radiology
1.5.3 Interventional Radiology
1.5.4 Interventional Cardiology
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size, Estimates and Forecasts
2.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2015-2026
2.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2015-2026
2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Competitor Landscape by Players
3.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers
3.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (2015-2020)
3.1.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2015-2020)
3.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers
3.2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2015-2020)
3.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue in 2019
3.2.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Manufacturers
3.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base Distribution, Product Types
3.4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Product Type
3.4.3 Date of International Manufacturers Enter into Contrast Agents for Magnetic Resonance Imaging (MRI) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type (2015-2020)
4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020)
4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2015-2020)
4.1.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Type (2021-2026)
4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Type (2021-2026)
4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Type (2021-2026)
4.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application (2015-2020)
5.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020)
5.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2015-2020)
5.1.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2015-2020)
5.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Application (2021-2026)
5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Application (2021-2026)
5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Application (2021-2026)
5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
6.1.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country
6.1.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Type
6.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Application

7 Europe
7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
7.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country
7.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Type
7.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) by Region
8.1.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region
8.1.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Type
8.3 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
9.1.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country
9.1.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Type
9.3 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
10.1.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country
10.1.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Type
10.3 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Application

11 Company Profiles
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Description and Business Overview
11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.1.5 GE Healthcare (US) Related Developments
11.2 Bracco Imaging (Italy)
11.2.1 Bracco Imaging (Italy) Corporation Information
11.2.2 Bracco Imaging (Italy) Description and Business Overview
11.2.3 Bracco Imaging (Italy) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.2.5 Bracco Imaging (Italy) Related Developments
11.3 Bayer HealthCare (Germany)
11.3.1 Bayer HealthCare (Germany) Corporation Information
11.3.2 Bayer HealthCare (Germany) Description and Business Overview
11.3.3 Bayer HealthCare (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.3.5 Bayer HealthCare (Germany) Related Developments
11.4 Guerbet (France)
11.4.1 Guerbet (France) Corporation Information
11.4.2 Guerbet (France) Description and Business Overview
11.4.3 Guerbet (France) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.4.5 Guerbet (France) Related Developments
11.5 Lantheus (US)
11.5.1 Lantheus (US) Corporation Information
11.5.2 Lantheus (US) Description and Business Overview
11.5.3 Lantheus (US) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.5.5 Lantheus (US) Related Developments
11.6 Daiichi Sankyo (Japan)
11.6.1 Daiichi Sankyo (Japan) Corporation Information
11.6.2 Daiichi Sankyo (Japan) Description and Business Overview
11.6.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.6.5 Daiichi Sankyo (Japan) Related Developments
11.7 Unijules Life Sciences (India)
11.7.1 Unijules Life Sciences (India) Corporation Information
11.7.2 Unijules Life Sciences (India) Description and Business Overview
11.7.3 Unijules Life Sciences (India) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.7.5 Unijules Life Sciences (India) Related Developments
11.8 J.B. Chemicals and Pharmaceuticals (India)
11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
11.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
11.8.3 J.B. Chemicals and Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.8.5 J.B. Chemicals and Pharmaceuticals (India) Related Developments
11.9 Spago Nanomedicine (Sweden)
11.9.1 Spago Nanomedicine (Sweden) Corporation Information
11.9.2 Spago Nanomedicine (Sweden) Description and Business Overview
11.9.3 Spago Nanomedicine (Sweden) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.9.5 Spago Nanomedicine (Sweden) Related Developments
11.10 Taejoon Pharm (South Korea)
11.10.1 Taejoon Pharm (South Korea) Corporation Information
11.10.2 Taejoon Pharm (South Korea) Description and Business Overview
11.10.3 Taejoon Pharm (South Korea) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.10.5 Taejoon Pharm (South Korea) Related Developments
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Description and Business Overview
11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered
11.1.5 GE Healthcare (US) Related Developments
11.12 Magnus Health (India)
11.12.1 Magnus Health (India) Corporation Information
11.12.2 Magnus Health (India) Description and Business Overview
11.12.3 Magnus Health (India) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Magnus Health (India) Products Offered
11.12.5 Magnus Health (India) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Estimates and Projections by Region
12.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Regions 2021-2026
12.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Regions 2021-2026
12.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast (2021-2026)
12.2.1 North America: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast (2021-2026)
12.2.2 North America: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast (2021-2026)
12.2.3 North America: Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Country (2021-2026)
12.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast (2021-2026)
12.3.1 Europe: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast (2021-2026)
12.3.2 Europe: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast (2021-2026)
12.3.3 Europe: Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Region (2021-2026)
12.5 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast (2021-2026)
12.5.1 Latin America: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast (2021-2026)
12.5.2 Latin America: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast (2021-2026)
12.5.3 Latin America: Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Contrast Agents for Magnetic Resonance Imaging (MRI) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Segments
Table 2. Ranking of Global Top Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Barium-based Contrast Media
Table 5. Major Manufacturers of Iodinated Contrast Media
Table 6. Major Manufacturers of Gadolinium-based Contrast Media
Table 7. Major Manufacturers of Microbubble Contrast Media
Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Regions (2015-2020)
Table 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Manufacturers (2015-2020)
Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contrast Agents for Magnetic Resonance Imaging (MRI) as of 2019)
Table 17. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Price (2015-2020) (USD/Pcs)
Table 20. Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Product Type
Table 22. Date of International Manufacturers Enter into Contrast Agents for Magnetic Resonance Imaging (MRI) Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Type (2015-2020)
Table 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Type (2015-2020)
Table 28. Contrast Agents for Magnetic Resonance Imaging (MRI) Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Application (2015-2020)
Table 31. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2015-2020) (K Pcs)
Table 32. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2015-2020)
Table 33. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2015-2020)
Table 35. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 36. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Table 37. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 38. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Table 39. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2015-2020)
Table 41. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2015-2020)
Table 43. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Table 45. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Table 55. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2015-2020)
Table 59. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Table 61. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Table 71. GE Healthcare (US) Corporation Information
Table 72. GE Healthcare (US) Description and Major Businesses
Table 73. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. GE Healthcare (US) Product
Table 75. GE Healthcare (US) Recent Development
Table 76. Bracco Imaging (Italy) Corporation Information
Table 77. Bracco Imaging (Italy) Description and Major Businesses
Table 78. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Bracco Imaging (Italy) Product
Table 80. Bracco Imaging (Italy) Recent Development
Table 81. Bayer HealthCare (Germany) Corporation Information
Table 82. Bayer HealthCare (Germany) Description and Major Businesses
Table 83. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Bayer HealthCare (Germany) Product
Table 85. Bayer HealthCare (Germany) Recent Development
Table 86. Guerbet (France) Corporation Information
Table 87. Guerbet (France) Description and Major Businesses
Table 88. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Guerbet (France) Product
Table 90. Guerbet (France) Recent Development
Table 91. Lantheus (US) Corporation Information
Table 92. Lantheus (US) Description and Major Businesses
Table 93. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Lantheus (US) Product
Table 95. Lantheus (US) Recent Development
Table 96. Daiichi Sankyo (Japan) Corporation Information
Table 97. Daiichi Sankyo (Japan) Description and Major Businesses
Table 98. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Daiichi Sankyo (Japan) Product
Table 100. Daiichi Sankyo (Japan) Recent Development
Table 101. Unijules Life Sciences (India) Corporation Information
Table 102. Unijules Life Sciences (India) Description and Major Businesses
Table 103. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Unijules Life Sciences (India) Product
Table 105. Unijules Life Sciences (India) Recent Development
Table 106. J.B. Chemicals and Pharmaceuticals (India) Corporation Information
Table 107. J.B. Chemicals and Pharmaceuticals (India) Description and Major Businesses
Table 108. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. J.B. Chemicals and Pharmaceuticals (India) Product
Table 110. J.B. Chemicals and Pharmaceuticals (India) Recent Development
Table 111. Spago Nanomedicine (Sweden) Corporation Information
Table 112. Spago Nanomedicine (Sweden) Description and Major Businesses
Table 113. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Spago Nanomedicine (Sweden) Product
Table 115. Spago Nanomedicine (Sweden) Recent Development
Table 116. Taejoon Pharm (South Korea) Corporation Information
Table 117. Taejoon Pharm (South Korea) Description and Major Businesses
Table 118. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Taejoon Pharm (South Korea) Product
Table 120. Taejoon Pharm (South Korea) Recent Development
Table 121. Jodas (India) Corporation Information
Table 122. Jodas (India) Description and Major Businesses
Table 123. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Jodas (India) Product
Table 125. Jodas (India) Recent Development
Table 126. Magnus Health (India) Corporation Information
Table 127. Magnus Health (India) Description and Major Businesses
Table 128. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Magnus Health (India) Product
Table 130. Magnus Health (India) Recent Development
Table 131. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Regions (2021-2026) (K Pcs)
Table 132. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. North America: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Europe: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Region (2021-2026) (K Pcs)
Table 140. Asia Pacific: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2021-2026) (K Pcs)
Table 142. Latin America: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. Middle East and Africa: Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Contrast Agents for Magnetic Resonance Imaging (MRI) Players
Table 149. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List
Table 150. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Product Picture
Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type in 2020 & 2026
Figure 3. Barium-based Contrast Media Product Picture
Figure 4. Iodinated Contrast Media Product Picture
Figure 5. Gadolinium-based Contrast Media Product Picture
Figure 6. Microbubble Contrast Media Product Picture
Figure 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application in 2020 & 2026
Figure 8. Radiology
Figure 9. Interventional Radiology
Figure 10. Interventional Cardiology
Figure 11. Contrast Agents for Magnetic Resonance Imaging (MRI) Report Years Considered
Figure 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size 2015-2026 (US$ Million)
Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2015-2026 (K Pcs)
Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2015-2020)
Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region in 2019
Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2015-2020)
Figure 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region in 2019
Figure 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue in 2019
Figure 21. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2015-2020)
Figure 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type in 2019
Figure 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2015-2020)
Figure 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type in 2019
Figure 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Price Range (2015-2020)
Figure 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2015-2020)
Figure 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application in 2019
Figure 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2015-2020)
Figure 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application in 2019
Figure 31. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2019
Figure 34. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2019
Figure 35. U.S. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2019
Figure 40. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2019
Figure 41. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2019
Figure 44. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2019
Figure 45. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2019
Figure 56. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2019
Figure 57. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region in 2019
Figure 60. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region in 2019
Figure 61. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2019
Figure 84. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2019
Figure 85. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2019
Figure 88. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2019
Figure 89. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2019
Figure 96. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2019
Figure 97. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2019
Figure 101. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2019
Figure 108. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2019
Figure 109. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed